Major deletions in the gene encoding the p53 tumor antigen cause lack of p53 expression in HL-60 cells.
AUTOR(ES)
Wolf, D
RESUMO
The tumor antigen p53 is overproduced in transformed cells of various species, including man. HL-60 is an exceptional human tumor cell line that does not express this protein. Hybridization of polyadenylylated mRNA of these cells with a human p53 cDNA probe (p53-H14), which we cloned, had indicated a total absence of the mature-size (3.0 kilobases) or any aberrant p53 mRNA species. Analysis of the genomic HL-60 DNA indicated that the p53 gene in these cells was significantly altered. Most of the gene was deleted, and the residual p53 sequences of these cells, which show weak homology, mapped to the corresponding 5' region of the p53 gene. In agreement with previously documented results, we found that HL-60 cells have an amplified c-myc gene. We suggest that the deficiency of the p53 protein in HL-60 cells could have been overcome by using an alternative metabolic pathway. The c-myc product is a candidate for such an alternative protein.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=397132Documentos Relacionados
- Expression of the mouse p53 cellular tumor antigen in monkey cells.
- Human p53 cellular tumor antigen: cDNA sequence and expression in COS cells.
- UV irradiation stimulates levels of p53 cellular tumor antigen in nontransformed mouse cells.
- Tumor necrosis factor inhibits MYC expression in HL-60 cells at the level of mRNA transcription.
- Adenosine deaminase mRNA expression is regulated posttranscriptionally during differentiation of HL-60 cells.